Benzofuran derivatives: a patent review

被引:113
作者
Dawood, Kamal M. [1 ]
机构
[1] Cairo Univ, Fac Sci, Dept Chem, Giza 12613, Egypt
关键词
anti-inflammatory; antimicrobial; antitumor; benzofurans; cytotoxic; HCV; HIV inhibitory; ANTIINFLAMMATORY ACTIVITY; BIOLOGICAL EVALUATION; ANTIMICROBIAL EVALUATION; CONVENIENT SYNTHESIS; CYTOTOXIC ACTIVITIES; INHIBITORS; POTENT; ANTICANCER; DISCOVERY; ANTITUMOR;
D O I
10.1517/13543776.2013.801455
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Introduction: Benzofuran moiety constitutes the core of several interesting pharmacologically active natural products. Benzofurans are among feasible potent active inhibitors against many diseases, viruses, microbes, fungus and enzymes. Several series of therapeutically important synthetic and naturally occurring benzofuran-containing compounds are reported in this chapter. Areas covered: The current chapter focuses on the recent applications of benzofuran scaffolds and their wide range of biological activities during 1999 - 2012. The pharmacological areas covered included anti-inflammatory, antitumor, cytotoxic, antimicrobial, antitubercular, antioxidant, antiplasmodial, trypanocidal and insecticidal activities as well as enzyme inhibitory, HCV and HIV inhibitory activities. Expert opinion: The results reported in the chapter indicate that some benzofuran derivatives may be useful as potent drugs. From the structure-activity relationship (SAR), the presence of certain functions like -OH, -OMe in the benzofuran derivatives contributed greatly in increasing the potency of their therapeutic activities when compared with standards. For example, presence of the -OH and -OMe have made some benzofuran compounds more potent HIV-RT inhibitory activity than the standard atevirdine, and more potent antitumor agent when compared with standards (fluorouracil, doxorubicin and cytarabine). In addition, the enzyme aromatase CYP19 inhibitory activity of benzofurans having -OH and -OMe were greater than that observed for the reference arimidex.
引用
收藏
页码:1133 / 1156
页数:24
相关论文
共 107 条
[1]   Stereoselective synthesis and antimicrobial activity of benzofuran-based (1E)-1-(piperidin-1-yl)-N2-arylamidrazones [J].
Abdel-Aziz, Hatem A. ;
Mekawey, Amal A. I. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (12) :4985-4997
[2]   Convenient synthesis and antimicrobial evaluation of some novel 2-substituted-3-methylbenzofuran derivatives [J].
Abdel-Aziz, Hatem A. ;
Mekawey, Amal A. I. ;
Dawood, Kamal M. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (09) :3637-3644
[3]  
Ameta KL., 2012, INT J ORGANIC CHEM, V2, P295, DOI [10.4236/ijoc.2012.223040, DOI 10.4236/IJOC.2012.223040]
[4]   Identification of benzofuran-4,5-diones as novel and selective non-hydroxamic acid, non-peptidomimetic based inhibitors of human peptide deformylase [J].
Antczak, Christophe ;
Shum, David ;
Bassit, Bhramdeo ;
Frattini, Mark G. ;
Li, Yueming ;
de Stanchina, Elisa ;
Scheinberg, David A. ;
Djaballah, Hakim .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (15) :4528-4532
[5]  
Asakawa K, 2009, Patent No. [JP 2009173629 A, 2009173629, JP2009173629A20090806]
[6]   Synthesis of cicerfuran, an antifungal benzofuran, and some related analogues [J].
Aslam, SN ;
Stevenson, PC ;
Phythian, SJ ;
Veitch, NC ;
Hall, DR .
TETRAHEDRON, 2006, 62 (17) :4214-4226
[7]   Synthesis and structure-activity relationships of novel benzofuran farnesyltransferase inhibitors [J].
Asoh, Kohsuke ;
Kohchi, Masami ;
Hyoudoh, Ikumi ;
Ohtsuka, Tatsuo ;
Masubuchi, Miyako ;
Kawasaki, Kenichi ;
Ebiike, Hirosato ;
Shiratori, Yasuhiko ;
Fukami, Takaaki A. ;
Kondoh, Osamu ;
Tsukaguchi, Toshiyuki ;
Ishii, Nobuya ;
Aoki, Yuko ;
Shimma, Nobuo ;
Sakaitani, Masahiro .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (06) :1753-1757
[8]   Preparation of new polycyclic compounds derived from benzofurans and furochromones. An approach to novel 1,2,3-thia-, and selena-diazolofurochromones of anticipated antitumor activities [J].
Atta, Sanaa M. Sh. ;
Farrag, Dalia S. ;
Sweed, Ayman M. K. ;
Abdel-Rahman, A. H. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (11) :4920-4927
[9]  
Babu V. Harinadha, 2007, Indian Journal of Pharmaceutical Sciences, V69, P470
[10]  
Babu VH., 2004, INDIAN J PHARM SCI, V66, P647